Home Barclays Capital Increases Eli Lilly & Co. Price Target to $58.00
 

Keywords :   


Barclays Capital Increases Eli Lilly & Co. Price Target to $58.00

2013-07-28 06:19:29| Biotech - Topix.net

The firm currently has an "equal weight" rating on the stock. Barclays Capital's price objective indicates a potential upside of 8.70% from the company's current price.

Tags: to price capital target

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
24.11Eastern North Pacific Tropical Weather Outlook
24.11Atlantic Tropical Weather Outlook
24.11
24.11sobbat DB4R
24.11RC10
24.11 Knicks
24.11 W6S-JP001
24.11SALOMON XLT 150
More »